Status:
COMPLETED
Implantable Long-Acting Pre-Exposure Prophylaxis For MSM
Lead Sponsor:
Elizabeth Arnold
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV Prevention
Eligibility:
MALE
18-45 years
Brief Summary
The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products in the ...
Detailed Description
The long-term goal of this project is to better understand factors at the patient and physician level that can be addressed to impact uptake of long-acting, implantable PrEP (LA-PrEP) products and ide...
Eligibility Criteria
Inclusion
- Patients must meet the following criteria:
- be a patient of one of the practices where physicians have agreed to participate or have been seen for a primary care visit in the past 12 months in the Dallas Austin, or San Antonio metro areas;
- be aged 18-45;
- be assigned male sex at birth and report having one or more male sexual partners in the past year; and
- be HIV negative.
- Physicians who are interested in participating must be a practicing primary care physician in the Dallas, San Antonio, or Austin metropolitan area and be willing to allow recruitment of patient participants from their practice.
Exclusion
- Those individuals who speak a language other than English or Spanish will be excluded as well as those who present with a cognitive or other impairment that would prevent them for consenting to participate in the study.
Key Trial Info
Start Date :
June 14 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 5 2025
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT05420207
Start Date
June 14 2024
End Date
September 5 2025
Last Update
October 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
2
Dell Medical School, UT-Austin
Austin, Texas, United States, 78712